Although DAT imaging possesses an inability to distinguish between parkinsonian syndromes, a recent study by Takaya et al. revealed that a combination of disease-specific perfusion patterns and striatal DAT activity accurately differentiates between atypical parkinsonian syndromes and Lewy body dementia [85]. This evidence concerns the gene SLC6A3 and Lewy body dementia.